×

Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema

Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.

Cornish EE, Teo KY, Gillies MC, Lim LL, Nguyen V, Wickremasinghe S, Mehta H, McAllister IL, Fraser-Bell S.

Br J Ophthalmol. 2021 Aug 2:bjophthalmol-2021-319839. doi: 10.1136/bjophthalmol-2021-319839. Online ahead of print.

PMID: 34340975 Free article.

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment